| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 4.498 | 21.208 | 34.235 | 43.234 | 59.224 | 66.415 | 80.067 | 84.477 | 95.842 |
| Total Income - EUR | - | 4.498 | 21.210 | 34.240 | 43.244 | 59.235 | 66.434 | 80.089 | 84.488 | 95.852 |
| Total Expenses - EUR | - | 8.756 | 17.523 | 24.727 | 32.230 | 38.462 | 43.423 | 57.543 | 60.527 | 63.992 |
| Gross Profit/Loss - EUR | - | -4.258 | 3.687 | 9.513 | 11.014 | 20.773 | 23.011 | 22.546 | 23.961 | 31.860 |
| Net Profit/Loss - EUR | - | -4.303 | 3.475 | 9.171 | 10.581 | 20.552 | 22.360 | 21.971 | 23.246 | 29.345 |
| Employees | - | 2 | 2 | 2 | 2 | 0 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Rt Diab Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 907 | 517 | 418 | 919 | 2.286 | 1.669 | 1.220 | 764 | 422 |
| Current Assets | - | 2.022 | 6.433 | 16.717 | 24.032 | 39.182 | 57.591 | 72.899 | 25.836 | 33.322 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 0 | 0 | 160 | 50 | 24 | 502 | 782 | 5.653 | 643 |
| Cash | - | 2.022 | 6.433 | 16.557 | 23.982 | 39.158 | 57.089 | 72.117 | 20.183 | 32.680 |
| Shareholders Funds | - | -4.258 | -711 | 8.473 | 18.890 | 39.084 | 55.018 | 71.076 | 23.294 | 29.592 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 7.212 | 7.708 | 8.685 | 6.061 | 2.383 | 4.241 | 3.043 | 3.306 | 4.153 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Rt Diab Srl